Infographic 3
Change in vaccine coverage from 2017 to 2021 cycle for children aged 2 years, by province and territory

Infographic description

The title of the infographic is "Change in vaccine coverage from 2017 to 2021 cycle for children aged 2 years, by province and territory"

This infographic is a table. It is composed of 12 rows and 14 columns.

The first column on the left represents all the vaccines included in the coverage estimates: DTaP, polio, Hib, measles, mumps, rubella, hepatitis B, varicella, men. C, pneumococcal and rotavirus.

The following columns are represented by each of the provinces in the sequence: Newfoundland and Labrador, Prince Edward Island, Nova Scotia, New Brunswick, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, the Northwest Territories and Nunavut.

The change in vaccination coverage for each vaccine from 2017 to 2021 are represented in the table by the colours green for an increase, red for a decrease and yellow when coverage remained stable. When the change in vaccination coverage is not reportable in a province or territory (see footnotes 2 and 4), this is represented by a period (".").

In Newfoundland and Labrador from 2017 to 2021, vaccine coverage for: DTaP decreased, polio was stable, Hib decreased, measles was stable, mumps was stable, rubella was stable, hepatitis B was not reported (see footnote 2), varicella was stable, men. C was stable, pneumococcal was stable, rotavirus was not reported (see footnote 4).

In Prince Edward Island from 2017 to 2021, vaccine coverage for: DTaP increased, polio was stable, Hib increased, measles was stable, mumps increased, rubella increased, hepatitis B increased, varicella was stable, men. C increased, pneumococcal increased, rotavirus increased.

In Nova Scotia from 2017 to 2021, vaccine coverage for: DTaP was stable, polio was stable, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was not reported (see footnote 2), varicella increased, men. C was stable, pneumococcal was stable, rotavirus was not reported (see footnote 4).

In New Brunswick from 2017 to 2021, vaccine coverage for: DTaP was stable, polio was stable, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was stable, varicella was stable, men. C was stable, pneumococcal was stable, rotavirus was not reported (see footnote 4).

In Quebec from 2017 to 2021, vaccine coverage for: DTaP was stable, polio was stable, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was stable, varicella increased, men. C was stable, pneumococcal was stable, rotavirus increased.

In Ontario from 2017 to 2021, vaccine coverage for: DTaP was stable, polio was stable, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was not reported (see footnote 2), varicella was stable, men. C was stable, pneumococcal increased, rotavirus increased.

In Manitoba from 2017 to 2021, vaccine coverage for: DTaP increased, polio was stable, Hib increased, measles was stable, mumps was stable, rubella was stable, hepatitis B was not reported (see footnote 2), varicella was stable, men. C increased, pneumococcal increased, rotavirus increased.

In Saskatchewan from 2017 to 2021, vaccine coverage for: DTaP was stable, polio was stable, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was not reported (see footnote 2), varicella was stable, men. C increased, pneumococcal was stable, rotavirus was stable.

In Alberta from 2017 to 2021, vaccine coverage for: DTaP was stable, polio decreased, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was not reported (see footnote 2), varicella was stable, men. C was stable, pneumococcal was stable, rotavirus was not reported (see footnote 4).

In British Columbia from 2017 to 2021, vaccine coverage for: DTaP increased, polio increased, Hib increased, measles was stable, mumps was stable, rubella was stable, hepatitis B increased, varicella increased, men. C increased, pneumococcal increased, rotavirus increased.

In Yukon from 2017 to 2021, vaccine coverage for: DTaP was stable, polio was stable, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was stable, varicella was stable, men. C was stable, pneumococcal was stable, rotavirus increased.

In the Northwest Territories from 2017 to 2021, vaccine coverage for: DTaP was stable, polio decreased, Hib was stable, measles was stable, mumps was stable, rubella was stable, hepatitis B was stable, varicella was stable, men. C was stable, pneumococcal was stable, rotavirus was stable.

In Nunavut from 2017 to 2021, vaccine coverage for: DTaP decreased, polio decreased, Hib decreased, measles decreased, mumps decreased, rubella decreased, hepatitis B decreased, varicella decreased, men. C decreased, pneumococcal decreased, rotavirus was not reported (see footnote 4).

Note(s): Changes in vaccination coverage estimates were limited to jurisdictions where programs for infants were in place in both 2017 and 2021.

Footnote 1: DTaP represents diphtheria, tetanus and pertussis vaccine.

Footnote 2: Coverage estimates were limited to jurisdictions where a 3-doses Hepatitis B vaccine program for infants was in place (British Columbia, Quebec, New Brunswick, Prince Edward Island, Yukon, the Northwest Territories and Nunavut).

Footnote 3: Men. C represents meningococcal type C.

Footnote 4: Coverage estimates were limited to jurisdictions where a 2-doses Rotavirus vaccine program for infants was in place (British Columbia, Saskatchewan, Ontario, Quebec, Prince Edward Island, Yukon, the Northwest Territories, Manitoba, Alberta and Newfoundland and Labrador) and a 3-doses Rotavirus vaccine program for New Brunswick.

Footnote 5: 2021 Nunavut coverage estimates and confidence intervals are of marginal quality due to high sampling variability and should be used with caution.

Source: Childhood National Immunization Coverage Survey, 2021 (5185).